| Style | Citing Format |
|---|---|
| MLA | Moradian N, et al.. "Cytokine Release Syndrome: Inhibition of Pro-Inflammatory Cytokines As a Solution for Reducing Covid-19 Mortality." European Cytokine Network, vol. 31, no. 3, 2020, pp. 81-93. |
| APA | Moradian N, Gouravani M, Salehi MA, Heidari A, Shafeghat M, Hamblin MR, Rezaei N (2020). Cytokine Release Syndrome: Inhibition of Pro-Inflammatory Cytokines As a Solution for Reducing Covid-19 Mortality. European Cytokine Network, 31(3), 81-93. |
| Chicago | Moradian N, Gouravani M, Salehi MA, Heidari A, Shafeghat M, Hamblin MR, Rezaei N. "Cytokine Release Syndrome: Inhibition of Pro-Inflammatory Cytokines As a Solution for Reducing Covid-19 Mortality." European Cytokine Network 31, no. 3 (2020): 81-93. |
| Harvard | Moradian N et al. (2020) 'Cytokine Release Syndrome: Inhibition of Pro-Inflammatory Cytokines As a Solution for Reducing Covid-19 Mortality', European Cytokine Network, 31(3), pp. 81-93. |
| Vancouver | Moradian N, Gouravani M, Salehi MA, Heidari A, Shafeghat M, Hamblin MR, et al.. Cytokine Release Syndrome: Inhibition of Pro-Inflammatory Cytokines As a Solution for Reducing Covid-19 Mortality. European Cytokine Network. 2020;31(3):81-93. |
| BibTex | @article{ author = {Moradian N and Gouravani M and Salehi MA and Heidari A and Shafeghat M and Hamblin MR and Rezaei N}, title = {Cytokine Release Syndrome: Inhibition of Pro-Inflammatory Cytokines As a Solution for Reducing Covid-19 Mortality}, journal = {European Cytokine Network}, volume = {31}, number = {3}, pages = {81-93}, year = {2020} } |
| RIS | TY - JOUR AU - Moradian N AU - Gouravani M AU - Salehi MA AU - Heidari A AU - Shafeghat M AU - Hamblin MR AU - Rezaei N TI - Cytokine Release Syndrome: Inhibition of Pro-Inflammatory Cytokines As a Solution for Reducing Covid-19 Mortality JO - European Cytokine Network VL - 31 IS - 3 SP - 81 EP - 93 PY - 2020 ER - |